Understanding how T cells make IFN-γ and IL-17 in kids with juvenile arthritis
Official title: Mechanisms of T Cell IFNy and IL-17 Production in Juvenile Idiopathic Arthritis
Funded at Vanderbilt University Medical Center · NIH-11392245 · Data updated 2026-11-12
A doctor-scientist at Vanderbilt is studying why certain immune cells in children with juvenile idiopathic arthritis produce inflammatory signals, with the goal of improving diagnosis and treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | August 24, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $163,836 |
| NIH project number | 5K08AR081405-05 |
| Project ID | NIH-11392245 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children with juvenile idiopathic arthritis who have or may have abnormalities in Th1/Th17 cell pathways.
✕Less likely to help
Children whose disease is not driven by Th1/Th17 pathways may see limited benefit.
What this research studies
This grant focuses on how specific T cells (Th1 and Th17) and their inflammatory signals (IFN-γ and IL-17) develop in juvenile idiopathic arthritis. The work includes studying genetic mutations in JIA patients and how these mutations affect the production of IL-17 and IFN-γ, potentially identifying new targets for therapy. The research combines laboratory experiments with training for the investigator to advance translational skills that could benefit children with JIA. By identifying biologic factors that influence disease pathways, the project aims to inform better diagnostic and treatment decisions for young patients. The plan emphasizes a pathway from basic biology to clinically relevant insights that could guide future trials and care.
Why it matters
Potential benefit: If successful, the work could lead to better diagnostics and targeted treatments for children with JIA.
How similar studies have gone: Previous studies have linked Th1/Th17 cells and IL-17/IFN-γ to JIA, with ongoing efforts to translate these findings into therapies.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Patrick, Anna Elizabeth — Vanderbilt University Medical Center
- Study coordinator: Patrick, Anna Elizabeth
Related research
Other NIH-funded projects on the same topics.
-
Deciphering What Drives Juvenile Idiopathic Arthritis in African American Children
This project looks at why African American children with juvenile idiopathic arthritis have more joint damage, using clinical data and genetic information to find factors that may explain the differences.
-
Lung disease linked to systemic juvenile idiopathic arthritis in children
This project looks at how ongoing immune activation and some arthritis medicines may cause lung inflammation and breathing problems in children with systemic juvenile idiopathic arthritis (SJIA).
-
Linking JIA Registry with Claims Data to Improve Understanding of Juvenile Arthritis
A study will connect the CARRA JIA patient registry with a large national claims database to see how well registry data match real-world care and outcomes for children with juvenile idiopathic arthritis.
-
Investigating the role of viruses and gut bacteria in arthritis flares in children
This study is looking at how certain viruses and bacteria in the gut might affect flare-ups of juvenile idiopathic arthritis in kids, hoping to find clues that could help manage these painful episodes better.
-
Understanding lung disease in children with systemic juvenile idiopathic arthritis
This study is looking at how a serious lung problem in some kids with systemic juvenile idiopathic arthritis happens, and it aims to find new ways to help treat or prevent this issue by understanding how a certain part of their immune system works.
-
Understanding how immune cells produce inflammatory signals in children with arthritis
This study is looking at how certain immune cells in children with juvenile idiopathic arthritis produce substances that cause inflammation, and it hopes to find genetic clues that could help improve how we diagnose and treat this condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.